Multiple Sclerosis Flashcards

1
Q

Definition of multiple sclerosis

A

a chronic progressive inflammatory disease involving damage to the myelin in the brain and spinal cord
- autoimmune disease (genetics, environment, 1st degree relatives)
- range of medical issues (physical function, depression, participation, personal social)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MS characteristics

A

the most common demyelinating nervous system disease to affect young adults
- mean onset 30 yrs old
- 70% onset 20-40 yrs old
- 10-20% after 60 yrs old
- more in females
- genetic predisposition
- triggered by environmental factors (sunshine, vit D, smoking)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MS is a dysfunction of?

A

oligendrocytes
- pro inflammatory agents released by microglial cells cause dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cells are reactive in MS?

A

T cells
- they are auto reactive in the periphery of the CNS
- T & B cells cross the weakened blood brain barrier
- T cells interact with B cells & make aberrant antibodies that target oligodendrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gray matter dysfunction in MS

A

gray matter pathology is closely associated with clinical disability than white matter (white matter injury is said to come independently)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epidemiology of MS

A
  • women > men
  • men have a worse prognosis/aggressive disease
  • extreme north/south latitudes
  • least common in warm climates
  • people who migrate from high risk to low risk regions before puberty reduce risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some geography/environmental triggers?

A
  • Epstein Barr virus
  • low vit D levels
  • reduced sunlight exposure
  • more common above the 45° latitude
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inflammatory demyelination

A

damage to the transmission of nerve impulses
1. inflammation to oligodendrocytes
2. oligodendrocytes demyelinate
3. inflammation subsides and symptoms reduce
4. oligodentrocytes remyelinate
5. more/repeated inflammation causes reduced repairing leading to axonal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does axonal damage equate to?

A

irreversible disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Plaques

A

focal loss of myeline leads to fibrous astrocytes and undergoes gliosis leading to plaques
–> axonal loss is present
50% spinal cord
25% optic nerve
25% brainstem/cerebellum

** plaques are the hallmark of MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MS classification: Relapsing-Remitting

A

(RRMS) unpredictable attacks which may or may not leave permanent deficits followed by periods of remission
~ 85% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MS classification: Secondary Progressive

A

(SPMS) initial relapsing remitting that suddenly begins to have decline without periods of remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MS classification: Primary Progressive

A

stead increase in disability without attack, gradual worsening of symptoms that does not respond to treatment prescriptions
–> progressive myelopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS classification: Benign

A

one occurrence with no reoccurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MS classification: Progressive Relapsing

A

steady decline since onset with superimposed attacks, progressive course with clear relapses
~ 5% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MS Expanded Disability Status Scale 0-4

A

0 = not affected
1 = no disability
2 = minimal disability
3 = moderate disability
4 = relatively severe disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MS Expanded Disability Status Scale 5-9

A

5 = disability affects daily routine
6 = assistance required to work
7 = restricted to wheelchair
8 = restricted to bed or wheelchair
9 = confined to bed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diagnosing MS

A

there is no single test, a collection of medical tests to confirm diagnosis (MRI, lumbar puncture)
- 2 lesions in at least 2 separate areas of the brain, spinal cord, or optic nerve
AND
- evidence of damage at 2 different points in time
AND
- rule out other diagnoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Differential diagnosis for MS

A
  • chronic low back pain (common 1st issue)
  • fibromyalgia
  • cervical spondyosis
  • herniated disc
  • mitochondrial disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Suspected MS symptom picture

A

significant lapse between the initial s/s (flares) and an additional episode of MS (can sometimes be years)
- some people may have a clinical isolated symptom (one event) and no other signs after that

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lumbar puncture: MS

A

the basic protein found in the CSF will be elevated during acute exacerbations of MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Visual evoked potential (VEP)

A

tests that measure the electrical activity of the brain (optic nerve) in response to stimulation of visual nerve pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the initial symptoms of MS?

A
  • females in their 20s
  • usually transient
  • fatigue
  • visual disturbances (double vision)
  • paresthesias, numbness, weakness, pins/needles (usually accompanied by LBP)
  • pain in B LEs (sudden and spontaneous electrical shock)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are some red flags in terms of MS symptoms?

A

double vision

pain in B LEs with a sudden electrical shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
S/S of MS flare/relapse/exacerbation
- numbness/tingling - fatigue - visual changes - weakness - changes in gait - brain fog - tremors - incontinence ** last longer than 24 hours (days, weeks, months)
26
Disease pathway of MS
1. initial diagnosis 2. exacerbation 3. period of remission 4. disease of management
27
Exacerbation and damage
the longer the length of an exacerbation the more damage may occur
28
Pseudo exacerbation
brought on by stress, over exertion, or heat - causes fatigue, brain fog, pain - will resolve in less than 24 hours on its own - DOES NOT MEAN THAT THE NERVOUS SYSTEM IS UNDERGOING DAMAGE
29
Fatigue
a subjective response perceived by an individual
30
Primary fatigue
autoimmune, lassitude (lethargy)
31
Indirect fatigue
medications that cause sleep
32
Neurologic fatigue
spasms, weakness, heat exposure, energy failure
33
Mitochondrial genetic variants and MS fatigue
deficient mitochondrial metabolism may generate more reactive oxygen specific (ROS) that wreak havoc in cells --> mitochondrial injury and subsequent energy failure are key factors in the induction of demyelination and neurodegeneration
34
Fatigue in MS
greater exposure to stress (deadlines at work, family conflict) and low mood were associated with higher fatigue levels while positive moods are associated with lower levels of fatigue * increased fatigue was associated with recent physical activity in people with MS
35
Uhtoff phenomenon
increase in core body temp (70% of people with MS experience) - physical exertions, hot water, warm temps are all correlated with fatigue - temporary symptoms usually don't increase MS symptoms - rapidly reversed with symptoms are removed
36
Motor system in MS
weakness (brain and spinal cord) - mono, hemi, quad paresis - deconditioning - dysarthria ataxia (80% of people have it) - cerebellar - dysmetria or dysdiadochokinesia - tremor
37
Spasms
sudden contractions/jumping of extremities (occurs in spinal cord pathology) - can be flexor or extensor - LE > UE
38
Hypertonicity/spasticity in MS
velocity sensitive resistance to muscle stretch, highly correlated with reduced function and QOL - spasticity seen with position changes, noxious stimuli, or physiologic stress - may be seen with increased pain, cold weather, tight clothing, or increased body temps
39
What can spasticity lead to?
contractures, skin breakdown, pain/sleep disturbances
40
Acute neuropathic pain
brought on by demyelination of sensory neurons (anteriolateral tract)
41
Trigeminal neuralgia
stabbing pain in the face or jaw, pain is not constant
42
Lhermitte's sign
brief stabbing electrical shock through the spinal cord
43
Chronic neuropathic pain
- brought on by stress (disease stress), fatigue, illness, or overheating - patient may feel dysesthesias or pruritis
44
Dysesthesia
painful sensations of the upper and lower limbs that are burning, lancing, prickling, stabbing, or icy
45
Pruritis
a form of dysesthesia (pins and needles), itching, burning, stabbing
46
Musculoskeletal pain
- muscular tightness/loss of ROM - spasticity, weakness, abnormal motion - compensatory patterns during movement - muscular pain from abnormal use or loading - muscular fatigue
47
Sensory impairments in MS
VISUAL - optic neuritis (20% will have in the first MS event) - double vision, blurry, painful eye movements - visual field loss, color desaturation - pupillary deficits SOMATOSENSORY/PROPRIOCEPTIVE - dysethesias (tingling, vibrations) - anesthesias - parasthesias - vestibular (dizziness/vertigo) NEUROPATHIC PAIN
48
Gait dysfunction in MS
decreased mobility due to other deficits - spasticity, weakness, sensory loss - coordination/ataxia - loss of sensation
49
Postural control and falls in MS
complex interaction between sensory inputs, motor output, processing, and context - leads to fractures from falls
50
What are the three common problems in MS in terms of postural control/falls?
1. delayed response to postural perturbations 2. increased body sway to quiet standing 3. inability to move outside of BOS
51
Bowel problems in MS
35-58% experience this - fecal retention - incontinence - constipation
52
Bladder problems in MS
52-97% experience this - urinary urgency - incontinence - overactive detrusor
53
Psychosocial problems in MS
depression is 2-3x more likely compared to other neuro conditions - associated with lower QOL
54
Cognitive problems in MS
- decreased verbal fluency and verbal memory - decreased processing speed - decreased executive functioning
55
Cycle of symptoms
- increase in fatigue and depression - exercise decreases - spasticity and constipation increase - bladder problems - decrease in sleep - decreased cognitive function
56
Disease modifying drugs: relapsing remitting MS
prevention of new inflammatory lesion and prevention of the development of secondary progressive MS
57
Disease modifying drugs: secondary and primary MS
prevention of loss of nerve fibers (neuroprotection) and allows for remyelination
58
Disease modifying drugs: Ocrevus
used in people with relapsing and progressive forms of MS - 2x/yr - 10 min IV drug - suppresses relapse acitivity and MRI lesions in 97% of people in 48 weeks
59
Outcomes of MS
- life expecacntny 6 years earlier than general population (72 women, 68 men) - higher mortality risk in patients with primary progressive MS
60
Progression of MS in the field
- it is highly variable - disease modifying therapy has reduced level of burden and progression - research on progressive forms - there has been earlier diagnosis and prompt medical intervention
61
Clinical picture: clinical isolated syndrome
- aucte/subacute onset of a monophasic episode suggestive of MS (longer than 24 hrs and affects optic nerve, brainstem, or spinal cord) - 30-70% of patients will develop MS - patients with optic neuritis have higher risk of MS development - age of onset 20-45 yrs, more in women
62
Clinical picture: relapsing remitting
- relapses over days to weeks with complete or partial remissions over months to years (~85% of cases) - age of onset 20-30 yrs, more in women
63
Clinical picture: progressive
progressive accumulation of disability after initial relapsing
64
Clinical picture: secondary progressive
~75% of relapsing remitting case within 15 years of initial diagnosis will develop this
65
Clinical picture: primary progressive
- steady functional worsening from the onset of disease - ~15% of cases - later onset than relapsing remitting - more in female
66
SUMMARY: MS
- progressive autoimmune CNS disease - myelin, spinal cord, cerebellum, brain - variable course and presentation - no cure, reduce amount of attacks
67
SUMMARY: functional impairments
- all facets of function and mobility - progressive loss of function - motor, cognitive, integumentary systems affected - risk for secondary complications from lack of movement and mobility